High-density lipoprotein cholesterol efflux capacity and incidence of coronary artery disease and cardiovascular mortality: a systematic review and meta-analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-density lipoprotein cholesterol efflux capacity and incidence of coronary artery disease and cardiovascular mortality: a systematic review and meta-analysis
Authors
Keywords
-
Journal
Lipids in Health and Disease
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-05-28
DOI
10.1186/s12944-022-01657-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New evidences on the association between high-density lipoprotein cholesterol and cardiovascular risk: a never ending research story
- (2022) Federica Fogacci et al. European Journal of Preventive Cardiology
- High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives
- (2021) Maria Pia Adorni et al. Cells
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Cholesterol efflux pathways, inflammation, and atherosclerosis
- (2021) Anouk G. Groenen et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis
- (2021) Jane J. Lee et al. Frontiers in Cardiovascular Medicine
- Composition-function analysis of HDL subpopulations: influence of lipid composition on particle functionality
- (2020) Katrin Niisuke et al. JOURNAL OF LIPID RESEARCH
- Cholesterol efflux capacity in coronary artery disease
- (2020) Huiming Ye et al. CORONARY ARTERY DISEASE
- High density lipoprotein functionality and cardiovascular events and mortality: A systematic review and meta-analysis
- (2020) Maria T Soria-Florido et al. ATHEROSCLEROSIS
- Cholesterol Efflux Capacity and Cardiovascular Disease: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study
- (2020) Andreas Ritsch et al. Biomedicines
- HDL and Reverse Cholesterol Transport
- (2019) Mireille Ouimet et al. CIRCULATION RESEARCH
- Direct Estimation of HDL-Mediated Cholesterol Efflux Capacity From Serum
- (2019) Sanna Kuusisto et al. CLINICAL CHEMISTRY
- Cholesterol Efflux Capacity, HDL Cholesterol, and Risk of Coronary Heart Disease: a Nested Case-Control Study in Men
- (2019) Leah E. Cahill et al. JOURNAL OF LIPID RESEARCH
- Lipid transfer to high‐density lipoproteins in coronary artery disease patients with and without previous cerebrovascular ischemic events
- (2019) Carlos J.D.G. Barbosa et al. CLINICAL CARDIOLOGY
- Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease
- (2018) Guisong Wang et al. PLoS One
- Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease
- (2018) Eithne M. Maguire et al. VASCULAR PHARMACOLOGY
- Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque
- (2018) Steven Shea et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity
- (2018) Mengdie Luo et al. Cardiovascular Diabetology
- Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis
- (2017) Abdur R. Khan et al. EUROPEAN HEART JOURNAL
- A survey of sub-Saharan gene flow into the Mediterranean at risk loci for coronary artery disease
- (2017) Miguel M Álvarez-Álvarez et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis
- (2017) Chengfeng Qiu et al. Lipids in Health and Disease
- ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity
- (2017) Mengdie Luo et al. Scientific Reports
- Prognostic Usefulness of Serum Cholesterol Efflux Capacity in Patients With Coronary Artery Disease
- (2016) Jianhua Zhang et al. AMERICAN JOURNAL OF CARDIOLOGY
- Cholesterol efflux capacity is an independent predictor of all-cause and cardiovascular mortality in patients with coronary artery disease: A prospective cohort study
- (2016) Chaoqun Liu et al. ATHEROSCLEROSIS
- Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease
- (2016) Kenji Norimatsu et al. HEART AND VESSELS
- Association between pretreatment Glasgow prognostic score and gastric cancer survival and clinicopathological features: a meta-analysis
- (2016) Bin Xiong et al. OncoTargets and Therapy
- Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial
- (2015) Stephen J. Nicholls et al. American Journal of Cardiovascular Drugs
- High-Density Lipoprotein (HDL) Phospholipid Content and Cholesterol Efflux Capacity Are Reduced in Patients With Very High HDL Cholesterol and Coronary Disease
- (2015) A. P. Agarwala et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease
- (2015) Tetsuya Ishikawa et al. ATHEROSCLEROSIS
- HDL Particle Size Is a Critical Determinant of ABCA1-Mediated Macrophage Cellular Cholesterol ExportNovelty and Significance
- (2015) Xian-Ming Du et al. CIRCULATION RESEARCH
- Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity
- (2015) Tomáš Vaisar et al. JOURNAL OF LIPID RESEARCH
- Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study
- (2015) Danish Saleheen et al. Lancet Diabetes & Endocrinology
- Humans With Atherosclerosis Have Impaired ABCA1 Cholesterol Efflux and Enhanced High-Density Lipoprotein Oxidation by Myeloperoxidase
- (2014) Baohai Shao et al. CIRCULATION RESEARCH
- Molecular Mechanisms of Cellular Cholesterol Efflux
- (2014) Michael C. Phillips JOURNAL OF BIOLOGICAL CHEMISTRY
- HDL and cardiovascular disease
- (2014) Daniel J Rader et al. LANCET
- HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
- (2014) Anand Rohatgi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reactive Oxygen Species in Inflammation and Tissue Injury
- (2013) Manish Mittal et al. ANTIOXIDANTS & REDOX SIGNALING
- Paradoxical Association of Enhanced Cholesterol Efflux With Increased Incident Cardiovascular Risks
- (2013) Xin-Min Li et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Altered Activation of Endothelial Anti- and Proapoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery Disease
- (2013) Meliana Riwanto et al. CIRCULATION
- Anti-oxidative and cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic cardiomyopathy
- (2013) Parin J. Patel et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
- (2011) Amit V. Khera et al. NEW ENGLAND JOURNAL OF MEDICINE
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- The versatility of HDL: a crucial anti-inflammatory regulator
- (2010) Marcus D. Säemann et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A2
- (2010) Wijtske Annema et al. JOURNAL OF LIPID RESEARCH
- Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease
- (2010) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammation Impairs Reverse Cholesterol Transport In Vivo
- (2009) Fiona C. McGillicuddy et al. CIRCULATION
- A comprehensive definition for metabolic syndrome
- (2009) P. L. Huang Disease Models & Mechanisms
- The metabolism and anti-atherogenic properties of HDL
- (2008) Kerry-Anne Rye et al. JOURNAL OF LIPID RESEARCH
- The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis
- (2008) Daniel J. Rader et al. JOURNAL OF LIPID RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started